Cholinergic and dopaminergic interactions alter attention and response inhibition in Long-Evans rats performing the 5-choice serial reaction time task

Keyphrases

• Long-Evans Rats 100%
• Response Inhibition 100%
• Impulsive Behavior 100%
• Attention Inhibition 100%
• 5-choice Serial Reaction Time Task 100%
• Receptor Antagonist 71%
• Nicotine 71%
• Impulsivity 57%
• Amphetamine 57%
• Dopamine 42%
• Acetylcholine 42%
• SCH23390 42%
• Eticlopride 42%
• Nicotinic Receptors 28%
• GBR 12909 28%
• Dopamine D1 Receptor 28%
• Attentional Behavior 28%
• Minimal Impact 14%
• Task Performance 14%
• Synaptic 14%
• Neurotransmission 14%
• Cholinergic Neurotransmission 14%
• Nicotinic Acetylcholine Receptor (nAChR) 14%
• Prefrontal Cortex 14%
• 2 Receptor 14%
• Dopaminergic Neurotransmission 14%
• Dopamine D2 Receptor (DRD2) 14%
• Flupenthixol 14%
• Dopaminergic Pathway 14%
• Mixed Effects 14%
• Acetylcholinesterase Inhibitors (AChEI) 14%
• Dopamine Release 14%
• Donepezil 14%
• Combination Trials 14%
• Mecamylamine 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Dopamine Receptor Stimulating Agent 100%
• Cholinergic Receptor Stimulating Agent 100%
• Long Evans Rat 100%
• Amphetamine 100%
• Acetylcholine 75%
• Receptor Antagonist 75%
• Eticlopride 75%
• Cholinesterase Inhibitor 25%
• Donepezil 25%
• Mecamylamine 25%
• Nicotinic Acetylcholine Receptor Agonist 25%
• Dopamine 1 Receptor 25%
• Flupentixol 25%
• Dopamine 2 Receptor Blocking Agent 25%
• Vanoxerine 25%
• Dopamine 1 Receptor Blocking Agent 25%

Neuroscience

• Behavior (Neuroscience) 100%
• Dopaminergic 100%
• Cholinergic 100%
• Receptor Antagonist 71%
• Impulsivity 57%
• Amphetamine 57%
• Acetylcholine 42%
• SCH 23390 42%
• Eticlopride 42%
• Synaptic Transmission 28%
• Dopamine Receptor D1 28%
• Prefrontal Cortex 14%
• Nicotinic Acetylcholine Receptor 14%
• Parasympathomimetic Drug 14%
• Dopamine Receptor D2 14%
• Flupentixol 14%
• Acetylcholinesterase Inhibitor 14%
• Dopamine Release 14%
• Mecamylamine 14%
• Donepezil 14%